Nanotechnology Drug Delivery Market is expected to grow at a CAGR of 19.4% during the forecast period. Global Nanotechnology Drug Delivery Market is expected to reach US$ 279.6Bn. by 2029. Various novel technologies for developing effective drug delivery systems came into existence among which nanotechnology platforms for achieving targeted drug delivery are gaining prominence nowadays. Research in the medical field includes the development of drug nanoparticles, polymeric and inorganic biodegradable nano-carriers for drug delivery, and surface engineering of carrier molecules.To know about the Research Methodology:- Request Free Sample Report The report contains a detailed list of factors that will drive and restrain the growth of the Nanotechnology Drug Delivery Market. Such as, rapidly expanding areas of research and development to develop novel nano-medicine are expected to drive the nanotechnology drug delivery market growth in the future. Additionally, one of the major factors assisting market growth is the growing prevalence of infectious diseases and cancer, developing nanotechnology research, and increasing demand for novel drug delivery systems. However, high cost coupled with stringent regulatory scenario hinders the market growth to some extent. Nanoparticles are expected to account for the largest xx% market share by 2029. The segment dominated the market as key nanoparticles like gold nanoparticles, dendrimers, and fullerenes are used in pharmaceutical drug delivery. The report offers a brief analysis of the major regions in the global nanotechnology drug delivery market, namely, APAC, Europe, North America, South America, and the Middle East & Africa. North America dominated the nanotechnology drug delivery market in 2018, because of high medical reimbursement facilities, and technological advancement. The APAC is projected to have the fastest growth, owing to a rapidly increasing population, an increase in consumer awareness, favorable government policies, modernization of healthcare infrastructure, and growing medical tourism industry in developing economies such as China, and India in this region. Nanotechnology drug delivery market report gives a competitive analysis of the individual standing of the companies against the global landscape of the medical industry. The forecast also provides the estimated trends in demand for the global market and their impact on the sizes of these companies to help the reader curate profitable business strategies. Such as Pfizer, Inc., AstraZeneca and Amgen signed agreements to collaborate with BIND Therapeutics to develop nano-medicines. These initiatives are expected to fuel the growth of the nanotechnology drug delivery market in the upcoming future. The objective of the report is to present comprehensive analysis of Global Nanotechnology Drug Delivery Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers the all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers. The report also helps in understanding Global Nanotechnology Drug Delivery Market dynamics, structure by analyzing the market segments, and project the Global Nanotechnology Drug Delivery Market size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Nanotechnology Drug Delivery Market make the report investor’s guide. The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis.
Scope of the Global Nanotechnology Drug Delivery Market: Inquire before buying
Global Nanotechnology Drug Delivery Market Report Coverage Details Base Year: 2021 Forecast Period: 2022-2029 Historical Data: 2017 to 2021 Market Size in 2021: US $ 67.70 Bn. Forecast Period 2022 to 2029 CAGR: 19.4% Market Size in 2029: US $ 279.6 Bn. Segments Covered: by Technology • Nanocrystals • Nanoparticles • Liposomes • Micelles • Nanotubes • Others by Application • Neurology • Oncology • Cardiovascular/Physiology • Anti-inflammatory/Immunology • Anti-infective • Others Global Nanotechnology Drug Delivery Market, by Region
• North America • Asia Pacific • Europe • Middle East & Africa • South AmericaKey players operating in the Global Nanotechnology Drug Delivery Market
• Johnson & Johnson • Merck & Co • Roche • Bayer • Novartis Pharmaceuticals • Pfizer • AstraZeneca • Amgen • Celgene Corporation • Angiotech Pharmaceuticals • Capsulution Pharma • AlphaRx Inc. • Calando Pharmaceuticals • Copernicus Therapeutics • Elan Corporation • Nanotherapeutics • PAR Pharmaceutica • Taiwan Liposome Co. • AbbVie, Inc • Amgen, Inc • Camarus AB • NanoCarrier Co., Ltd. • Selecta Biosciences • Starpharma Holdings Limited Frequently Asked Questions: 1. Which region has the largest share in Global Nanotechnology Drug Delivery Market? Ans: Asia Pacific region holds the highest share in 2021. 2. What is the growth rate of Global Nanotechnology Drug Delivery Market? Ans: The Global Nanotechnology Drug Delivery Market is growing at a CAGR of 19.4% during forecasting period 2022-2029. 3. What is scope of the Global Nanotechnology Drug Delivery Market report? Ans: Global Nanotechnology Drug Delivery Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. What is the study period of this market? Ans: The Global Nanotechnology Drug Delivery Market is studied from 2021 to 2029.
1. Nanotechnology Drug Delivery Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Nanotechnology Drug Delivery Market: Dynamics 2.1. Nanotechnology Drug Delivery Market Trends by Region 2.1.1. North America Nanotechnology Drug Delivery Market Trends 2.1.2. Europe Nanotechnology Drug Delivery Market Trends 2.1.3. Asia Pacific Nanotechnology Drug Delivery Market Trends 2.1.4. Middle East and Africa Nanotechnology Drug Delivery Market Trends 2.1.5. South America Nanotechnology Drug Delivery Market Trends 2.2. Nanotechnology Drug Delivery Market Dynamics by Region 2.2.1. North America 2.2.1.1. North America Nanotechnology Drug Delivery Market Drivers 2.2.1.2. North America Nanotechnology Drug Delivery Market Restraints 2.2.1.3. North America Nanotechnology Drug Delivery Market Opportunities 2.2.1.4. North America Nanotechnology Drug Delivery Market Challenges 2.2.2. Europe 2.2.2.1. Europe Nanotechnology Drug Delivery Market Drivers 2.2.2.2. Europe Nanotechnology Drug Delivery Market Restraints 2.2.2.3. Europe Nanotechnology Drug Delivery Market Opportunities 2.2.2.4. Europe Nanotechnology Drug Delivery Market Challenges 2.2.3. Asia Pacific 2.2.3.1. Asia Pacific Nanotechnology Drug Delivery Market Drivers 2.2.3.2. Asia Pacific Nanotechnology Drug Delivery Market Restraints 2.2.3.3. Asia Pacific Nanotechnology Drug Delivery Market Opportunities 2.2.3.4. Asia Pacific Nanotechnology Drug Delivery Market Challenges 2.2.4. Middle East and Africa 2.2.4.1. Middle East and Africa Nanotechnology Drug Delivery Market Drivers 2.2.4.2. Middle East and Africa Nanotechnology Drug Delivery Market Restraints 2.2.4.3. Middle East and Africa Nanotechnology Drug Delivery Market Opportunities 2.2.4.4. Middle East and Africa Nanotechnology Drug Delivery Market Challenges 2.2.5. South America 2.2.5.1. South America Nanotechnology Drug Delivery Market Drivers 2.2.5.2. South America Nanotechnology Drug Delivery Market Restraints 2.2.5.3. South America Nanotechnology Drug Delivery Market Opportunities 2.2.5.4. South America Nanotechnology Drug Delivery Market Challenges 2.3. PORTER’s Five Forces Analysis 2.4. PESTLE Analysis 2.5. Technology Roadmap 2.6. Regulatory Landscape by Region 2.6.1. North America 2.6.2. Europe 2.6.3. Asia Pacific 2.6.4. Middle East and Africa 2.6.5. South America 2.7. Key Opinion Leader Analysis For Nanotechnology Drug Delivery Industry 2.8. Analysis of Government Schemes and Initiatives For Nanotechnology Drug Delivery Industry 2.9. Nanotechnology Drug Delivery Market Trade Analysis 2.10. The Global Pandemic Impact on Nanotechnology Drug Delivery Market 3. Nanotechnology Drug Delivery Market: Global Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million) 2021-2029 3.1. Nanotechnology Drug Delivery Market Size and Forecast, by Technology (2021-2029) 3.1.1. Nanocrystals 3.1.2. Nanoparticles 3.1.3. Liposomes 3.1.4. Micelles 3.1.5. Nanotubes 3.1.6. Others 3.2. Nanotechnology Drug Delivery Market Size and Forecast, by Application (2021-2029) 3.2.1. Neurology 3.2.2. Oncology 3.2.3. Cardiovascular/Physiology 3.2.4. Anti-inflammatory/Immunology 3.2.5. Anti-infective 3.2.6. Others 3.3. Nanotechnology Drug Delivery Market Size and Forecast, by Region (2021-2029) 3.3.1. North America 3.3.2. Europe 3.3.3. Asia Pacific 3.3.4. Middle East and Africa 3.3.5. South America 4. North America Nanotechnology Drug Delivery Market Size and Forecast by Segmentation (by Value in USD Million) 2021-2029 4.1. North America Nanotechnology Drug Delivery Market Size and Forecast, by Technology (2021-2029) 4.1.1. Nanocrystals 4.1.2. Nanoparticles 4.1.3. Liposomes 4.1.4. Micelles 4.1.5. Nanotubes 4.1.6. Others 4.2. North America Nanotechnology Drug Delivery Market Size and Forecast, by Application (2021-2029) 4.2.1. Neurology 4.2.2. Oncology 4.2.3. Cardiovascular/Physiology 4.2.4. Anti-inflammatory/Immunology 4.2.5. Anti-infective 4.2.6. Others 4.3. North America Nanotechnology Drug Delivery Market Size and Forecast, by Country (2021-2029) 4.3.1. United States 4.3.1.1. United States Nanotechnology Drug Delivery Market Size and Forecast, by Technology (2021-2029) 4.3.1.1.1. Nanocrystals 4.3.1.1.2. Nanoparticles 4.3.1.1.3. Liposomes 4.3.1.1.4. Micelles 4.3.1.1.5. Nanotubes 4.3.1.1.6. Others 4.3.1.2. United States Nanotechnology Drug Delivery Market Size and Forecast, by Application (2021-2029) 4.3.1.2.1. Neurology 4.3.1.2.2. Oncology 4.3.1.2.3. Cardiovascular/Physiology 4.3.1.2.4. Anti-inflammatory/Immunology 4.3.1.2.5. Anti-infective 4.3.1.2.6. Others 4.3.2. Canada 4.3.2.1. Canada Nanotechnology Drug Delivery Market Size and Forecast, by Technology (2021-2029) 4.3.2.1.1. Nanocrystals 4.3.2.1.2. Nanoparticles 4.3.2.1.3. Liposomes 4.3.2.1.4. Micelles 4.3.2.1.5. Nanotubes 4.3.2.1.6. Others 4.3.2.2. Canada Nanotechnology Drug Delivery Market Size and Forecast, by Application (2021-2029) 4.3.2.2.1. Neurology 4.3.2.2.2. Oncology 4.3.2.2.3. Cardiovascular/Physiology 4.3.2.2.4. Anti-inflammatory/Immunology 4.3.2.2.5. Anti-infective 4.3.2.2.6. Others 4.3.3. Mexico 4.3.3.1. Mexico Nanotechnology Drug Delivery Market Size and Forecast, by Technology (2021-2029) 4.3.3.1.1. Nanocrystals 4.3.3.1.2. Nanoparticles 4.3.3.1.3. Liposomes 4.3.3.1.4. Micelles 4.3.3.1.5. Nanotubes 4.3.3.1.6. Others 4.3.3.2. Mexico Nanotechnology Drug Delivery Market Size and Forecast, by Application (2021-2029) 4.3.3.2.1. Neurology 4.3.3.2.2. Oncology 4.3.3.2.3. Cardiovascular/Physiology 4.3.3.2.4. Anti-inflammatory/Immunology 4.3.3.2.5. Anti-infective 4.3.3.2.6. Others 5. Europe Nanotechnology Drug Delivery Market Size and Forecast by Segmentation (by Value in USD Million) 2021-2029 5.1. Europe Nanotechnology Drug Delivery Market Size and Forecast, by Technology (2021-2029) 5.2. Europe Nanotechnology Drug Delivery Market Size and Forecast, by Application (2021-2029) 5.3. Europe Nanotechnology Drug Delivery Market Size and Forecast, by Country (2021-2029) 5.3.1. United Kingdom 5.3.1.1. United Kingdom Nanotechnology Drug Delivery Market Size and Forecast, by Technology (2021-2029) 5.3.1.2. United Kingdom Nanotechnology Drug Delivery Market Size and Forecast, by Application (2021-2029) 5.3.2. France 5.3.2.1. France Nanotechnology Drug Delivery Market Size and Forecast, by Technology (2021-2029) 5.3.2.2. France Nanotechnology Drug Delivery Market Size and Forecast, by Application (2021-2029) 5.3.3. Germany 5.3.3.1. Germany Nanotechnology Drug Delivery Market Size and Forecast, by Technology (2021-2029) 5.3.3.2. Germany Nanotechnology Drug Delivery Market Size and Forecast, by Application (2021-2029) 5.3.4. Italy 5.3.4.1. Italy Nanotechnology Drug Delivery Market Size and Forecast, by Technology (2021-2029) 5.3.4.2. Italy Nanotechnology Drug Delivery Market Size and Forecast, by Application (2021-2029) 5.3.5. Spain 5.3.5.1. Spain Nanotechnology Drug Delivery Market Size and Forecast, by Technology (2021-2029) 5.3.5.2. Spain Nanotechnology Drug Delivery Market Size and Forecast, by Application (2021-2029) 5.3.6. Sweden 5.3.6.1. Sweden Nanotechnology Drug Delivery Market Size and Forecast, by Technology (2021-2029) 5.3.6.2. Sweden Nanotechnology Drug Delivery Market Size and Forecast, by Application (2021-2029) 5.3.7. Austria 5.3.7.1. Austria Nanotechnology Drug Delivery Market Size and Forecast, by Technology (2021-2029) 5.3.7.2. Austria Nanotechnology Drug Delivery Market Size and Forecast, by Application (2021-2029) 5.3.8. Rest of Europe 5.3.8.1. Rest of Europe Nanotechnology Drug Delivery Market Size and Forecast, by Technology (2021-2029) 5.3.8.2. Rest of Europe Nanotechnology Drug Delivery Market Size and Forecast, by Application (2021-2029) 6. Asia Pacific Nanotechnology Drug Delivery Market Size and Forecast by Segmentation (by Value in USD Million) 2021-2029 6.1. Asia Pacific Nanotechnology Drug Delivery Market Size and Forecast, by Technology (2021-2029) 6.2. Asia Pacific Nanotechnology Drug Delivery Market Size and Forecast, by Application (2021-2029) 6.3. Asia Pacific Nanotechnology Drug Delivery Market Size and Forecast, by Country (2021-2029) 6.3.1. China 6.3.1.1. China Nanotechnology Drug Delivery Market Size and Forecast, by Technology (2021-2029) 6.3.1.2. China Nanotechnology Drug Delivery Market Size and Forecast, by Application (2021-2029) 6.3.2. S Korea 6.3.2.1. S Korea Nanotechnology Drug Delivery Market Size and Forecast, by Technology (2021-2029) 6.3.2.2. S Korea Nanotechnology Drug Delivery Market Size and Forecast, by Application (2021-2029) 6.3.3. Japan 6.3.3.1. Japan Nanotechnology Drug Delivery Market Size and Forecast, by Technology (2021-2029) 6.3.3.2. Japan Nanotechnology Drug Delivery Market Size and Forecast, by Application (2021-2029) 6.3.4. India 6.3.4.1. India Nanotechnology Drug Delivery Market Size and Forecast, by Technology (2021-2029) 6.3.4.2. India Nanotechnology Drug Delivery Market Size and Forecast, by Application (2021-2029) 6.3.5. Australia 6.3.5.1. Australia Nanotechnology Drug Delivery Market Size and Forecast, by Technology (2021-2029) 6.3.5.2. Australia Nanotechnology Drug Delivery Market Size and Forecast, by Application (2021-2029) 6.3.6. Indonesia 6.3.6.1. Indonesia Nanotechnology Drug Delivery Market Size and Forecast, by Technology (2021-2029) 6.3.6.2. Indonesia Nanotechnology Drug Delivery Market Size and Forecast, by Application (2021-2029) 6.3.7. Malaysia 6.3.7.1. Malaysia Nanotechnology Drug Delivery Market Size and Forecast, by Technology (2021-2029) 6.3.7.2. Malaysia Nanotechnology Drug Delivery Market Size and Forecast, by Application (2021-2029) 6.3.8. Vietnam 6.3.8.1. Vietnam Nanotechnology Drug Delivery Market Size and Forecast, by Technology (2021-2029) 6.3.8.2. Vietnam Nanotechnology Drug Delivery Market Size and Forecast, by Application (2021-2029) 6.3.9. Taiwan 6.3.9.1. Taiwan Nanotechnology Drug Delivery Market Size and Forecast, by Technology (2021-2029) 6.3.9.2. Taiwan Nanotechnology Drug Delivery Market Size and Forecast, by Application (2021-2029) 6.3.10. Rest of Asia Pacific 6.3.10.1. Rest of Asia Pacific Nanotechnology Drug Delivery Market Size and Forecast, by Technology (2021-2029) 6.3.10.2. Rest of Asia Pacific Nanotechnology Drug Delivery Market Size and Forecast, by Application (2021-2029) 7. Middle East and Africa Nanotechnology Drug Delivery Market Size and Forecast by Segmentation (by Value in USD Million) 2021-2029 7.1. Middle East and Africa Nanotechnology Drug Delivery Market Size and Forecast, by Technology (2021-2029) 7.2. Middle East and Africa Nanotechnology Drug Delivery Market Size and Forecast, by Application (2021-2029) 7.3. Middle East and Africa Nanotechnology Drug Delivery Market Size and Forecast, by Country (2021-2029) 7.3.1. South Africa 7.3.1.1. South Africa Nanotechnology Drug Delivery Market Size and Forecast, by Technology (2021-2029) 7.3.1.2. South Africa Nanotechnology Drug Delivery Market Size and Forecast, by Application (2021-2029) 7.3.2. GCC 7.3.2.1. GCC Nanotechnology Drug Delivery Market Size and Forecast, by Technology (2021-2029) 7.3.2.2. GCC Nanotechnology Drug Delivery Market Size and Forecast, by Application (2021-2029) 7.3.3. Nigeria 7.3.3.1. Nigeria Nanotechnology Drug Delivery Market Size and Forecast, by Technology (2021-2029) 7.3.3.2. Nigeria Nanotechnology Drug Delivery Market Size and Forecast, by Application (2021-2029) 7.3.4. Rest of ME&A 7.3.4.1. Rest of ME&A Nanotechnology Drug Delivery Market Size and Forecast, by Technology (2021-2029) 7.3.4.2. Rest of ME&A Nanotechnology Drug Delivery Market Size and Forecast, by Application (2021-2029) 8. South America Nanotechnology Drug Delivery Market Size and Forecast by Segmentation (by Value in USD Million) 2021-2029 8.1. South America Nanotechnology Drug Delivery Market Size and Forecast, by Technology (2021-2029) 8.2. South America Nanotechnology Drug Delivery Market Size and Forecast, by Application (2021-2029) 8.3. South America Nanotechnology Drug Delivery Market Size and Forecast, by Country (2021-2029) 8.3.1. Brazil 8.3.1.1. Brazil Nanotechnology Drug Delivery Market Size and Forecast, by Technology (2021-2029) 8.3.1.2. Brazil Nanotechnology Drug Delivery Market Size and Forecast, by Application (2021-2029) 8.3.2. Argentina 8.3.2.1. Argentina Nanotechnology Drug Delivery Market Size and Forecast, by Technology (2021-2029) 8.3.2.2. Argentina Nanotechnology Drug Delivery Market Size and Forecast, by Application (2021-2029) 8.3.3. Rest Of South America 8.3.3.1. Rest Of South America Nanotechnology Drug Delivery Market Size and Forecast, by Technology (2021-2029) 8.3.3.2. Rest Of South America Nanotechnology Drug Delivery Market Size and Forecast, by Application (2021-2029) 9. Global Nanotechnology Drug Delivery Market: Competitive Landscape 9.1. MMR Competition Matrix 9.2. Competitive Landscape 9.3. Key Players Benchmarking 9.3.1. Company Name 9.3.2. Business Segment 9.3.3. End-user Segment 9.3.4. Revenue (2021) 9.3.5. Company Locations 9.4. Leading Nanotechnology Drug Delivery Market Companies, by market capitalization 9.5. Market Structure 9.5.1. Market Leaders 9.5.2. Market Followers 9.5.3. Emerging Players 9.6. Mergers and Acquisitions Details 10. Company Profile: Key Players 10.1. Johnson & Johnson 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Scale of Operation (small, medium, and large) 10.1.7. Details on Partnership 10.1.8. Regulatory Accreditations and Certifications Received by Them 10.1.9. Awards Received by the Firm 10.1.10. Recent Developments 10.2. Merck & Co 10.3. Roche 10.4. Bayer 10.5. Novartis Pharmaceuticals 10.6. Pfizer 10.7. AstraZeneca 10.8. Amgen 10.9. Celgene Corporation 10.10. Angiotech Pharmaceuticals 10.11. Capsulution Pharma 10.12. AlphaRx Inc. 10.13. Calando Pharmaceuticals 10.14. Copernicus Therapeutics 10.15. Elan Corporation 10.16. Nanotherapeutics 10.17. PAR Pharmaceutica 10.18. Taiwan Liposome Co. 10.19. AbbVie, Inc 10.20. Amgen, Inc 10.21. Camarus AB 10.22. NanoCarrier Co., Ltd. 10.23. Selecta Biosciences 10.24. Starpharma Holdings Limited 11. Key Findings 12. Industry Recommendations 13. Nanotechnology Drug Delivery Market: Research Methodology 14. Terms and Glossary